Cargando…

Cost-effectiveness of varicella and herpes zoster vaccination in Sweden: An economic evaluation using a dynamic transmission model

OBJECTIVES: Comprehensive cost-effectiveness analyses of introducing varicella and/or herpes zoster vaccination in the Swedish national vaccination programme. DESIGN: Cost-effectiveness analyses based on epidemiological results from a specifically developed transmission model. SETTING: National vacc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wolff, Ellen, Widgren, Katarina, Scalia Tomba, Gianpaolo, Roth, Adam, Lep, Tiia, Andersson, Sören
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118323/ https://www.ncbi.nlm.nih.gov/pubmed/33984060 http://dx.doi.org/10.1371/journal.pone.0251644

Ejemplares similares

The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster
por: Marangi, Luigi, et al.
Publicado: (2017)

Herpes Zoster and Varicella
por: Fordyce, A. Dingwall
Publicado: (1919)

Herpes Zoster and Varicella
por: Chatterjee, Bijoy Krishna
Publicado: (1929)

Perspectives on the Impact of Varicella Immunization on Herpes Zoster. A Model-Based Evaluation from Three European Countries
por: Poletti, Piero, et al.
Publicado: (2013)

Estimating Age-Specific Immunity and Force of Infection of Varicella Zoster Virus in Norway Using Mixture Models
por: Del Fava, Emanuele, et al.
Publicado: (2016)

Varicella Vaccination Alters the Chronological Trends of Herpes Zoster and Varicella
por: Wu, Po-Yuan, et al.
Publicado: (2013)

Varicella caused by airborne transmission of a localised herpes zoster infection in a family
por: Hatsushika, Yumi, et al.
Publicado: (2021)

RELATION OF VARICELLA TO HERPES ZOSTER : I. STATISTICAL OBSERVATIONS.
por: Rivers, T. M., et al.
Publicado: (1929)

Varicella and herpes zoster vaccine development: lessons learned
por: Warren-Gash, Charlotte, et al.
Publicado: (2017)

The positive duration of varicella zoster immunoglobulin M antibody test in herpes zoster
por: Min, Seong-Won, et al.
Publicado: (2016)

Tozinameran: Varicella zoster virus meningitis and herpes zoster infections : case report
Publicado: (2022)

RELATION OF VARICELLA TO HERPES ZOSTER : II. CLINICAL AND EXPERIMENTAL OBSERVATIONS.
por: Rivers, T. M., et al.
Publicado: (1929)

Herpes Zoster in an Immunocompetent Child without a History of Varicella
por: Shang, Bing-Shiau, et al.
Publicado: (2021)

An adult co-presented with varicella and herpes zoster caused by varicella zoster virus genotype J, China: a case report
por: Xie, Guangcheng, et al.
Publicado: (2020)

The changing epidemiology of varicella and herpes zoster in Hong Kong before universal varicella vaccination in 2014
por: Chan, D. Y. W., et al.
Publicado: (2018)

Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster
por: van Lier, Alies, et al.
Publicado: (2015)

Modeling the Impact of Exogenous Boosting and Universal Varicella Vaccination on the Clinical and Economic Burden of Varicella and Herpes Zoster in a Dynamic Population for England and Wales
por: Sharomi, Oluwaseun, et al.
Publicado: (2022)

Severe Herpes Zoster Following Varicella Vaccination in Immunocompetent Young Children
por: Moodley, Amaran, et al.
Publicado: (2019)

Tozinameran: Herpes varicella-zoster virus infection: 2 case reports
Publicado: (2022)

Herpes Simplex Virus and Varicella Zoster Virus Infections in Cancer Patients
por: Tayyar, Ralph, et al.
Publicado: (2023)

Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries
por: Damm, Oliver, et al.
Publicado: (2015)

Burden of herpes zoster and post-herpetic neuralgia in Sweden
por: Nilsson, Jonas, et al.
Publicado: (2015)

The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting
por: Sauboin, Christophe, et al.
Publicado: (2019)

Recombinant varicella zoster virus glycoprotein E antigen vaccine for prevention of herpes zoster and postherpetic neuralgia
Publicado: (2021)

The Efficacy of Amenamevir for the Treatment of Disseminated Herpes Zoster Complicated with Probable Varicella-zoster Pneumonia in an Immunocompromised Patient
por: Kobayashi, Hiroki, et al.
Publicado: (2021)

Trends in Hospitalizations With Primary Varicella and Herpes Zoster During the Prevaricella and Initial Postvaricella and Herpes Zoster Vaccine Eras, Connecticut, 1994–2012
por: Humes, Elizabeth A., et al.
Publicado: (2015)

Varicella zoster virus transmission dynamics in Vojvodina, Serbia
por: Medić, Snežana, et al.
Publicado: (2018)

THE ETIOLOGIC AGENTS OF VARICELLA AND HERPES ZOSTER : SEROLOGIC STUDIES WITH THE VIRUSES AS PROPAGATED IN VITRO
por: Weller, Thomas H., et al.
Publicado: (1958)

THE ETIOLOGIC AGENTS OF VARICELLA AND HERPES ZOSTER : ISOLATION, PROPAGATION, AND CULTURAL CHARACTERISTICS IN VITRO
por: Weller, Thomas H., et al.
Publicado: (1958)

Concurrent Reactivation of Varicella Zoster Virus and Herpes Simplex Virus in an Immunocompetent Child
por: Park, Hyun-Ho, et al.
Publicado: (2004)

A Case of Severe Herpes Zoster and Varicella Occurring Simultaneously in an Aged Patient
por: Overton, R. E.
Publicado: (1926)

Prevalence of a history of prior varicella/herpes zoster infection in multiple sclerosis
por: Manouchehrinia, Ali, et al.
Publicado: (2017)

Herpes zoster duplex bilateralis symmetricus in an immunocompromised patient with recent varicella infection
por: Amonchaisakda, Nuntouchaporn, et al.
Publicado: (2021)

1461. The Impact of Universal Varicella Vaccination on Herpes Zoster Incidence in the United States
por: Leung, Jessica W, et al.
Publicado: (2022)

Diagnostic Usefulness of Varicella Zoster Virus-Specific Immunoglobulin (Ig) A and IgG in Patients With Herpes Zoster
por: Choi, Sungim, et al.
Publicado: (2022)

Varicella Zoster Virus-Specific Hyperimmunoglobulin in the Adjuvant Treatment of Immunocompromised Herpes Zoster Patients: A Case Series
por: Terheyden, Patrick, et al.
Publicado: (2023)

Epidemiology of Varicella Zoster Virus and Herpes Zoster Virus in Gulf Cooperation Council Countries: A Review of the Literature
por: Badur, Selim, et al.
Publicado: (2022)

Herpes Zoster and Recurrent Herpes Zoster
por: Shiraki, Kimiyasu, et al.
Publicado: (2017)

Preventing varicella zoster infection in immunocompromised adults with varicella zoster–specific immunoglobulins
por: Gelman, Daniel, et al.
Publicado: (2023)

Varicella and Herpes Zoster in Madrid, based on the Sentinel General Practitioner Network: 1997–2004
por: Pérez-Farinós, Napoleón, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_k7en8tij9hnoo2eftobuadptnu